Özlem Ünal UZUN, Büşra ÇAVDARLI, Selen KARALÖK

Mitochondrial trifunctional protein deficiency as a polyneuropathy etiology in childhood

Background. The mitochondrial trifunctional protein (MTP) is a multienzyme complex of the fatty acid beta- oxidation cycle. Mitochondrial trifunctional protein deficiency (MTPD), a rare condition that leads to failure of converting certain fats to energy is characterized by decreased activity of three enzymes in the enzyme complex. Signs and symptoms of MTPD may present during infancy or later in life; those that begin after infancy include hypotonia, muscle pain, rhabdomyolysis, and peripheral neuropathy. We report a Turkish boy diagnosed with MTPD after being investigated for polyneuropathy of unknown origin since infancy. Case. A 5.5-year-old male patient was admitted to our clinic with complaints of weakness in the arms and legs, physical inactivity compared to his peers, fatigue, weakness and, difficulty in climbing stairs since infancy. Electroneuromyography (ENMG) analysis showed moderate symmetric distal sensorimotor and axonal neuropathy. On the background of chronic polyneuropathy, the patient had acute relapsing episodes with progressively worsening severity in the follow-up period until 12.5 years of age. Whole exome sequencing (WES) was performed in the patient and, revealed that the patient had a homozygous c.1390G>A (p.Gly464Ser) pathogenic variant of the HADHB gene. Although rhabdomyolysis is a well defined accompanying clinical feature of MTPD, it was not present in our patient who only had worsening muscle weakness during attacks. Conclusion. On the background of chronic polyneuropathy and acute relapsing episodes triggered by fasting or illnesses and rhabdomyolysis physicians should suspect disorders of the fatty acid beta-oxidation cycle.

PDF

___

1. Morris AAM, Spiekerkoetter U. Disorders of mitochondrial fatty acid oxidation and riboflavin metabolism. In: Saudubray JM, Baumgartner MR, Walter J (eds). Inborn Metabolic Diseases: Diagnosis and Treatment (6th ed). Berlin: Springer 2016: 204- 205. https://doi.org/10.1007/978-3-662-49771-5_12

2. Spiekerkoetter U, Sun B, Khuchua Z, Bennett MJ, Strauss AW. Molecular and phenotypic heterogeneity in mitochondrial trifunctional protein deficiency due to beta-subunit mutations. Hum Mutat 2003; 21: 598-607. https://doi.org/10.1002/humu.10211

3. Marucci G, Cianferotti L, Beck-Pecoz P, et al. Rare diseases in clinical endocrinology: a taxonomic classification system. J Endocrinol Invest 2015; 38

4. den Boer ME, Dionisi-Vici C, Chakrapani A, van Thuijl AO, Wanders RJ, Wijburg FA. Mitochondrial trifunctional protein deficiency: a severe fatty acid oxidation disorder with cardiac and neurologic involvement. J Pediatr 2003; 142: 684-689. https://doi. org/10.1067/mpd.2003.231

5. Richards S, Aziz N, Bale S, et al; ACMG Laboratory Quality Assurance Committee. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 2015; 17: 405-424. https://doi.org/10.1038/ gim.2015.30

6. Desmet FO, Hamroun D, Lalande M, Collod-Béroud G, Claustres M, Béroud C. Human Splicing Finder: an online bioinformatics tool to predict splicing signals. Nucleic Acids Res 2009; 37: e67. https://doi. org/10.1093/nar/gkp215

7. Pettersen EF, Goddard TD, Huang CC, et al. UCSF Chimera--a visualization system for exploratory research and analysis. J Comput Chem 2004; 25: 1605-1612. https://doi.org/10.1002/jcc.20084

8. Rodrigues CH, Pires DE, Ascher DB. DynaMut: predicting the impact of mutations on protein conformation, flexibility and stability. Nucleic Acids Res 2018; 46: W350-W355. https://doi.org/10.1093/ nar/gky300

9. Sedel F, Barnerias C, Dubourg O, Desguerres I, Lyon-Caen O, Saudubray JM. Peripheral neuropathy and inborn errors of metabolism in adults. J Inherit Metab Dis 2007; 30: 642-653. https://doi.org/10.1007/ s10545-007-0684-x

10. Carrier Genetic Test Igenomix CGT. Diseases list. Available at: https://cgt.igenomix.ae/diseases-list/

11. Fu X, Zheng F, Zhang Y, et al. Mitochondrial trifunctional protein deficiency due to HADHB gene mutation in a Chinese family. Mol Genet Metab Rep 2015; 5: 80-84. https://doi.org/10.1016/j. ymgmr.2015.10.015

12. Naiki M, Ochi N, Kato YS, et al. Mutations in HADHB, which encodes the β-subunit of mitochondrial trifunctional protein, cause infantile onset hypoparathyroidism and peripheral polyneuropathy. Am J Med Genet A 2014; 164: 1180- 1187. https://doi.org/10.1002/ajmg.a.36434

13. van Vliet P, Berden AE, van Schie MKM, et al. Peripheral neuropathy, episodic rhabdomyolysis, and hypoparathyroidism in a patient with mitochondrial trifunctional protein deficiency JIMD Rep 2018; 38: 101-105. https://doi. org/10.1007/8904_2017_37

14. Yamamoto Y, Matsui N, Hiramatsu Y, et al. Mitochondrial trifunctional protein deficiency: an adult patient with similar progress to Charcot- Marie-Tooth disease. Rinsho Shinkeigaku 2017; 57: 82-87. https://doi.org/10.5692/clinicalneurol.cn- 000976

15. Purevsuren J, Fukao T, Hasegawa Y, et al. Clinical and molecular aspects of Japanese patients with mitochondrial trifunctional protein deficiency. Mol Genet Metab 2009; 98: 372-377. https://doi. org/10.1016/j.ymgme.2009.07.011